Changing Japanese Heathcare Scene - Health Care Transition Leads Evaluation of Pharma Market -
To read the full story
COMMENTARY
- Taking on Solid Tumors - 9: ADCs Surge Ahead as TCEs Strive for a Foothold
July 18, 2025
- FY2024 Sees Divergence in I/O Drug Sales, Keytruda Thrives while Rivals Face Pricing Headwinds
July 4, 2025
- Honebuto 2025 Approved - The Real Battle for Pharma Lies Ahead
June 23, 2025
- Next Wave of ALS Drugs Emerging as Novartis, Nipro Enter Development Fray
May 27, 2025
- Impact of US Drug Policy: President Trump Shaking the World of Pharma
May 19, 2025
I recently attended a fantastic conference hosted by Prospection Japan, and one speaker, Dr. Joe Ledsam, really blew me away with his insights. He shared some truly fascinating developments about how AI is set to revolutionize healthcare, from how doctors…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…